MPC Therapeutics

MPC Therapeutics is a biotechnology company founded on the belief that mitochondria represent untapped therapeutic targets. We develop molecules that modulate mitochondrial function and trigger cellular re-programming to fight cancer and degenerative diseases. Our lead program aims to improve the performance and durability of CAR-T cell therapy. Preparation of CAR-T cells in the presence of our compound have been shown in different preclinical cancer models to dramatically improve survival compared to standard CAR-T cells. In addition, the team plans to position its proprietary molecules as novel treatments for alopecia and Hematopoeitic Stem Cell (HSCs) therapies.